Market players are forecasting a slowdown in private equity healthcare deal-making, with investors said to be “scrambling to figure out” the impact of a Trump presidency.
Tag Archives | Affordable Care Act
In the second of a two-part series, Constitution Capital Partners’ Robert Hatch highlights that while healthcare has earned its reputation as a shelter sector, in the wake of a massive regulatory overhaul, potential hazards may exist.
In the first of a two-part series, Robert Hatch of Constitution Capital Partners explores some key takeaways for investors through analyzing over 1,000 healthcare buyouts, dating back to 1987.
The healthcare focused firm’s investment will be used to expand ExactCare’s geographic footprint as it rolls out its specialist pharmacy services across the US.
This may be the last round of capital as a private company for healthcare IT services and data specialist Health Catalyst, according to its chief executive Dan Burton.
The firm is seeking healthcare companies that can drive down the cost of healthcare while delivering better outcomes for patients.
As the healthcare sector continues to evolve, private equity dealflow should remain strong, according to Bain & Co partner Nirad Jain.
Mansa Capital’s managing partner, Ruben King-Shaw, says a growing gap in supply and demand in US healthcare is driving demand for healthcare services and technology innovation and investment.
A growing but fragmented market and increasingly onerous regulation have created conditions ripe for US dermatology clinic consolidation.
Joshua Weisbrod, partner in Bain & Co’s global healthcare practice, discusses how private equity investors bound risk in the healthcare heavy space.